Effect and safety for clearance of vancomycin-resistant enterococci in feces through fecal microbiota transplantatio
Not Applicable
- Conditions
- Codes for special purposes
- Registration Number
- KCT0007585
- Lead Sponsor
- Inha University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 280
Inclusion Criteria
[1] FMT group
1. Men and women over 18 years of age
2. VRE is continuously detected more than 2 times in stool test
[2] Control group
1. Men and women over 18 years of age
2. VRE is detected more than 2 times in stool test
3. FMT treatment is rejected but those who agree to participate in this study as a control group
Exclusion Criteria
1. Patients who need urgent treatment such as acute infectious diseases. But include the patients with C. difficile colitis.
2. Patients with the disease-causing severe immunosuppression.
3. Pregnant women
4. Patients to be inappropriate for the study when judged by the researchers
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VRE negative conversion rate within 90 days
- Secondary Outcome Measures
Name Time Method VRE negative conversion rate within 30 days ;Adverse effect;Changes of microbiome in intestine after FMT